Koers Zhejiang Xinguang Pharmaceutical Co., Ltd.
Aandelen
300519
CNE1000027T3
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,98 CNY | -1,22% | -2,41% | -21,67% |
Omzet 2021 | 321 mln. 44,41 mln. 41,15 mln. | Omzet 2022 | 351 mln. 48,64 mln. 45,08 mln. | Marktkapitalisatie | 2,51 mld. 347 mln. 321 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 114 mln. 15,78 mln. 14,62 mln. | Nettowinst (verlies) 2022 | 109 mln. 15,09 mln. 13,98 mln. | EV/omzet 2021 | 7,83 x |
Nettoliquiditeiten 2021 | 719 mln. 99,46 mln. 92,17 mln. | Nettoliquiditeiten 2022 | 737 mln. 102 mln. 94,52 mln. | EV/omzet 2022 | 5,03 x |
K/w-verhouding 2021 |
28,4
x | K/w-verhouding 2022 |
23
x | Werknemers | 308 |
Dividendrendement 2021 |
2,97% | Dividendrendement 2022 |
3,19% | Vrij verhandelbaar | 41,75% |
1 dag | -1,22% | ||
1 week | -2,41% | ||
Lopende maand | +8,08% | ||
1 maand | -0,15% | ||
3 maanden | -20,17% | ||
6 maanden | -17,48% | ||
Lopend jaar | -21,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yue Jun Wang
CEO | Chief Executive Officer | 70 | 01-01-98 |
Bin Bin Xing
DFI | Director of Finance/CFO | 49 | 01-01-03 |
Zhu Ping Sun
CHM | Chairman | 61 | 18-11-98 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hu Gen Wang
BRD | Director/Board Member | 74 | 24-08-18 |
Yue Jun Wang
CEO | Chief Executive Officer | 70 | 01-01-98 |
Fu Yin Qiu
BRD | Director/Board Member | 62 | 01-01-01 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 12,98 | -1,22% | 5 644 100 |
27-03-24 | 13,14 | +4,12% | 6 610 950 |
26-03-24 | 12,62 | -0,08% | 2 181 400 |
25-03-24 | 12,63 | -3,59% | 3 195 200 |
22-03-24 | 13,1 | -3,18% | 3 692 100 |
slotkoers Shenzhen S.E., 28 maart 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,67% | 291 mln. | |
+28,67% | 46,19 mld. | |
+18,57% | 22,88 mld. | |
+20,11% | 14,18 mld. | |
+0,55% | 12,63 mld. | |
+46,16% | 12,07 mld. | |
-1,55% | 7,85 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+7,80% | 5,14 mld. |